Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children

Affiliations

• ¹ State Key Laboratory of Experimental Hematology, Department of Hematology, Beijing Boren Hospital, 100070, Beijing, China. panj@borenhospital.com.
• ² State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China.
• ³ Cytology Laboratory, Beijing Boren Hospital, 100070, Beijing, China.
• ⁴ Department of Hematology, Beijing Boren Hospital, 100070, Beijing, China.
• ⁵ School of Biomedical Engineering, Capital Medical University, 100069, Beijing, China.
• ⁶ Medical Laboratory, Beijing Boren Hospital, 100070, Beijing, China.
• ⁷ Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 200433, Shanghai, China.
• ⁸ Medical Laboratory, Beijing Boren Hospital, 100070, Beijing, China. zhengql@borenhospital.com.
• ⁹ State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300020, Tianjin, China. fengxiaoming@ihcams.ac.cn.
• ¹⁰ Central Laboratory, Fujian Medical University Union Hospital, 350001, Fuzhou, China. fengxiaoming@ihcams.ac.cn.